Split‐Face Study Using a 1,927‐nm Thulium Fiber Fractional Laser to Treat Photoaging and Melasma in Asian Skin

BACKGROUND Although the 1,927‐nm thulium fiber fractional laser is effective and safe for treating photoaging, clinical data regarding this modality remain limited. OBJECTIVE To investigate the efficacy and safety of the 1,927‐nm thulium fiber fractional laser for treating photoaging and melasma in Asians. METHODS Twenty‐five participants received three laser treatments (at 3‐week intervals) on the half of the face with more‐severe photoaging and melasma. Independent investigators evaluated clinical improvement 2 and 6 months after the final treatment. Improvement in melasma was evaluated using the Melasma Area and Severity Index. Subjective satisfaction rates were also evaluated. Adverse events were assessed, and pain was scored using a visual analog scale (VAS). Histologic changes were observed using immunohistochemical staining. RESULTS Clinical improvement of photodamaged facial skin was remarkable on the treatment side. Most participants reported that their subjective satisfaction rate was greater than slight satisfaction. Downtime for healing required approximately 1 week. No severe adverse events occurred. Mean VAS score during treatment was 4.8. Collagen regeneration and melanin decrease were observed histologically. CONCLUSION The 1,927‐nm thulium fiber fractional laser is a safe, effective treatment for photoaging and melasma in Asians.

[1]  A. Manosroi,et al.  Topical 5% tranexamic acid for the treatment of melasma in Asians: A double-blind randomized controlled clinical trial , 2012, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.

[2]  L. Schmitt,et al.  Is non‐ablative 1550‐nm fractional photothermolysis an effective modality to treat melasma? Results from a prospective controlled single‐blinded trial in 51 patients , 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

[3]  Kristel D. Polder,et al.  Treatment of Melasma Using a Novel 1,927‐nm Fractional Thulium Fiber Laser: A Pilot Study , 2012, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[4]  Kristel D. Polder,et al.  1,927‐nm Fractional Thulium Fiber Laser for the Treatment of Nonfacial Photodamage: A Pilot Study , 2011, Dermatologic Surgery.

[5]  J. Beek,et al.  Non‐ablative 1,550 nm fractional laser therapy versus triple topical therapy for the treatment of melasma: A randomized controlled split‐face study , 2010, Lasers in surgery and medicine.

[6]  Dong Hun Lee,et al.  Treatment of Melasma in Asian Skin Using a Fractional 1,550‐nm Laser: An Open Clinical Study , 2009, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[7]  L. Izikson,et al.  Resolution of blue minocycline pigmentation of the face after fractional photothermolysis , 2008, Lasers in surgery and medicine.

[8]  D. Goldberg,et al.  Histologic and ultrastructural analysis of melasma after fractional resurfacing , 2008, Lasers in surgery and medicine.

[9]  R. Moy,et al.  Nevus of Ota successfully treated by fractional photothermolysis using a fractionated 1440-nm Nd:YAG laser. , 2008, Archives of dermatology.

[10]  S. Shek,et al.  The prevalence and risk factors of post‐inflammatory hyperpigmentation after fractional resurfacing in Asians , 2007, Lasers in surgery and medicine.

[11]  Stacey K Naito.  Fractional photothermolysis treatment for resistant melasma in Chinese females , 2007, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.

[12]  E. Tanzi,et al.  Fractional Photothermolysis: Treatment of Facial and Nonfacial Cutaneous Photodamage with a 1,550‐nm Erbium‐Doped Fiber Laser , 2007, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[13]  R. Geronemus.  Fractional photothermolysis: Current and future applications , 2006, Lasers in surgery and medicine.

[14]  R. Fitzpatrick,et al.  The Treatment of Melasma with Fractional Photothermolysis: A Pilot Study , 2005, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[15]  R. Anderson,et al.  Fractional Photothermolysis: A New Concept for Cutaneous Remodeling Using Microscopic Patterns of Thermal Injury , 2004, Lasers in surgery and medicine.

[16]  J. Chung,et al.  Photoaging in Asians , 2003, Photodermatology, photoimmunology & photomedicine.

[17]  T. Alster.  Cutaneous resurfacing with CO2 and erbium: YAG lasers: preoperative, intraoperative, and postoperative considerations. , 1999, Plastic and reconstructive surgery.

[18]  T. Hamilton,et al.  Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial. , 1994, Archives of dermatology.

[19]  Vaneeta M. Sheth,et al.  Melasma: a comprehensive update: part II. , 2011, Journal of the American Academy of Dermatology.

[20]  B. Hantash,et al.  Laser-induced transepidermal elimination of dermal content by fractional photothermolysis. , 2006, Journal of biomedical optics.